---
$id: https://graph.org.ai/products/commodity/51182013
$type: Product
source: UNSPSC
code: "51182013"
title: "Stanozolol"
class: "51182000"
classTitle: "Androgens and androgen inhibitors"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Stanozolol

**UNSPSC Code**: 51182013
**Class**: [Androgens and androgen inhibitors](Androgens and androgen inhibitors.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a therapeutic androgen and anabolic steroid with the molecular formula C21H32N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4R1VB9P8V3, chemically known as 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethylcyclopenta(7,8)-phenanthro(2,3-c)pyrazol-1-ol but generally known as stanozolol, which bears US NIH Compound Identifier 25249. European Medicines Agency schedules Stanozolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10641MIG. The term STANOZOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 10, 1968, List 8). World Health Organization schedules stanozolol in its Anatomical Therapeutic Chemical (ATC) Classification. STANOZOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule stanozolol under HS 29372900 and SITC 54153. As of Q4 2014, STANOZOLOL remains the US FDA Preferred Term for this commodity. Stanozolol bears US NLM identifiers UMLS ID C0592142 and NCI Concept Code C842. SMILES: OC1(C2(C(C3C(C4(C(CC3)CC3[NH]NCC3C4)C)CC2)CC1)C)C.

